GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (STU:82P) » Definitions » Sale Of Investment

Pacira BioSciences (STU:82P) Sale Of Investment : €142.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacira BioSciences Sale Of Investment?

Pacira BioSciences's sale of investment for the three months ended in Mar. 2024 was €39.9 Mil. It means Pacira BioSciences gained €39.9 Mil from selling investments. Pacira BioSciences's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €142.5 Mil.

Compared with last quarter (€33.1 Mil in Dec. 2023 ), Pacira BioSciences gained more money from selling investments in Mar. 2024 (€39.9 Mil).


Pacira BioSciences Sale Of Investment Historical Data

The historical data trend for Pacira BioSciences's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences Sale Of Investment Chart

Pacira BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 287.52 253.07 953.85 224.27 217.39

Pacira BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.91 30.92 38.63 33.10 39.89

Pacira BioSciences Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €142.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacira BioSciences Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (STU:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (STU:82P) Headlines

No Headlines